Aggravation of food‐related behavior in an adolescent with Prader‐Willi syndrome treated with fluvoxamine and fluoxetine | Zendy

Kohn Yoav | Zendy; Weizman Abraham | Zendy; Apter Alan | Zendy

Premium

Aggravation of food‐related behavior in an adolescent with Prader‐Willi syndrome treated with fluvoxamine and fluoxetine

Author(s) -

Kohn Yoav,

Weizman Abraham,

Apter Alan

Publication year - 2001

Publication title -

international journal of eating disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.785

H-Index - 138

eISSN - 1098-108X

pISSN - 0276-3478

DOI - 10.1002/eat.1062

Subject(s) - fluoxetine , fluvoxamine , appetite , psychology , psychiatry , pharmacotherapy , reuptake inhibitor , obesity , weight gain , medicine , body weight , pediatrics , antidepressant , serotonin , receptor , anxiety

Prader‐Willi Syndrome is a congenital multisystem disorder, characterized by a typical dysmorphism, mental retardation, hyperphagia due to insatiable appetite, and resultant morbid obesity. Psychiatric symptoms include obsessions and temper tantrums. Method Pharmacotherapy is experimental with a few reports of successful fluoxetine treatment. Results We report an aggravation in the food‐related symptoms and a consequent weight gain in an adolescent with Prader‐Willi syndrome, who was treated with fluvoxamine and fluoxetine. © 2001 by John Wiley & Sons, Inc. Int J Eat Disord 30: 113–117, 2001.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research